Viral and Host Factors in the Transmission and Pathogenesis of HIV
| Status: | Recruiting |
|---|---|
| Conditions: | Infectious Disease, HIV / AIDS |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 16 - Any |
| Updated: | 1/13/2018 |
| Start Date: | July 2000 |
| End Date: | July 2019 |
| Contact: | Melissa La Mar |
| Email: | mlamar@rockefeller.edu |
| Phone: | 212-327-7280 |
To study the collection of blood from individuals known to be at high risk for HIV-infection
or who have been recently infected with HIV.
The data collected are used for diagnostic, prognostic and management decisions as outlined
by current HIV-1 Treatment Guidelines.
or who have been recently infected with HIV.
The data collected are used for diagnostic, prognostic and management decisions as outlined
by current HIV-1 Treatment Guidelines.
This phlebotomy protocol permits the collection of blood from individuals known to be at high
risk for HIV-infection or who have been recently infected with HIV.
Participants will have from 10 to 60 ml (approximately 1 to 4 tablespoons) of blood drawn for
one or all of the following tests:
- T cell subset enumeration
- Serologic reactivity with HIV antigens
- Viral load assays by bDNA, PCR, or RT-PCR
- Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology,
RPR)
- HIV-1 Resistance Testing
These data are used for diagnostic, prognostic and management decisions as outlined by
current HIV-1 Treatment Guidelines
risk for HIV-infection or who have been recently infected with HIV.
Participants will have from 10 to 60 ml (approximately 1 to 4 tablespoons) of blood drawn for
one or all of the following tests:
- T cell subset enumeration
- Serologic reactivity with HIV antigens
- Viral load assays by bDNA, PCR, or RT-PCR
- Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology,
RPR)
- HIV-1 Resistance Testing
These data are used for diagnostic, prognostic and management decisions as outlined by
current HIV-1 Treatment Guidelines
Inclusion Criteria:
recently infected with HIV-1 HIV-1 negative, and at high risk for infection
Exclusion Criteria:
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials